Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following managemen...

Bristol-Myers Squibb said a late-stage Opdivo study showed the medicine failed to prolong overall survival in patients with a type of newly diagnosed brain cancer.Th...

An experimental drug from Myovant Sciences met its main goal in a Phase 3 trial of women with uterine fibroids, results which keep the biotech on track to file the d...

The FDA approved Pfizer and Merck KGaA's Bavencio in combination with Inlyta for the first-line treatment of patients with advanced kidney cancer. (Pfizer) Pfize...

In a possible relief for Pfizer and for abrocitinib as a JAK inhibitor, fewer patients on it than on placebo stopped therapy due to side effects. (Tracy Staton) P...

An experimental drug developed by Ionis Pharmaceuticals and Roche could offer a way forward to treat Huntington's disease, nearly three decades after researchers ...

An approval for GSK's Trelegy in asthma patients could help the company offset the continued fall of its long-time blockbuster Advair. (GlaxoSmithKline) With gen...